Thomas Davis
22Patents
7h-index
36Co-inventors
69Inventor score
Filing activity: Oct 19, 1990 → Nov 19, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USD651840S1 | Upper body elevator | General | 28 | Expired |
| US7767689B2 | Carboline derivatives useful in the treatment of cancer | Physics | 25 | Active |
| US8076352B2 | Administration of carboline derivatives useful in the treatment of cancer and other diseases | Human Necessities | 23 | Active |
| USD663426S1 | Leg and feet elevator | General | 21 | Active |
| USD875412S1 | Full-body elevator | General | 15 | Active |
| US8076353B2 | Inhibition of VEGF translation | Chemistry; Metallurgy | 13 | Active |
| US8372860B2 | Carboline derivatives useful in the inhibition of angiogenesis | Physics | 11 | Active |
| US8703726B2 | Methods for treating prostate conditions | Human Necessities | 6 | Active |
| US9351964B2 | Methods for treating cancer and non-neoplastic conditions | Emerging Cross-Sectional Technologies | 5 | Active |
| US8697662B2 | Methods for treating Kaposi sarcoma | Human Necessities | 5 | Active |
| USD760346S1 | UV liquid treatment system housing | General | 4 | Active |
| US7992241B2 | Upper body elevator | Human Necessities | 4 | Active |
| US8680113B2 | BMI-1 protein expression modulators | Human Necessities | 3 | Active |
| US8710459B1 | UV liquid treatment system | Chemistry; Metallurgy | 3 | Active |
| USD331289S | Ladder attached paint can support | General | 3 | Expired |
| US10428050B2 | Substituted reverse pyrimidine Bmi-1 inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US11869677B2 | Breeder blanket for nuclear fusion reactor | Emerging Cross-Sectional Technologies | 0 | Active |
| US12023335B2 | Method for treating pancreatic cancer | Human Necessities | 0 | Active |
| US12315643B2 | Layered neutron shielding | Emerging Cross-Sectional Technologies | 0 | Active |
| US8614063B2 | Methods for screening for compounds for treating cancer | Chemistry; Metallurgy | 0 | Active |
| US11180483B2 | Substituted reverse pyrimidine Bmi-1 inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US9782286B2 | Full body elevator | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.